US › Healthcare

Windtree Therapeutics Inc (WINT)

US · Healthcare · Biotechnology

$0.000.00%

Last close · 2026-08-04

Latest quarter · ended 2025-09-30

Revenue

Net profit

$-28.1M

Profit YoY

-921.6%

EPS

$-1.08

EPS estimate

$-0.06

EPS came in at -1.08 against a street estimate of -0.06 — a miss of 1700.0%.

Key statistics

Market cap

$13,483

P/E

0.0

Forward P/E

0.4

P/B

0.61

Book value

$-0.34

EPS (TTM)

$10.77

52-week high

$0.59

52-week low

$0.00

50-day MA

$0.01

200-day MA

$0.03

Beta

1.61

Analyst view

Analysts rate Windtree Therapeutics Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $4.00.

Shareholding

Institutions

0.02%

Largest institutional holders

Fund	Stake
Urban Wealth Management, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Windtree Therapeutics Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.